Key Details
Price
$7.34Annual ROE
-336.16%Beta
0.06Events Calendar
Next earnings date:
Mar 06, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Mar 06, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 22, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NEW YORK CITY, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
LOS ANGELES--(BUSINESS WIRE)--NEUE Investors Have the Opportunity to Join Investigation of NeueHealth, Inc. with the Schall Law Firm.
Health insurer NeueHealth said on Monday that an affiliate of New Enterprise Associates and a consortium of investors would take it private at an enterprise value of about $1.3 billion.
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its.
NeueHealth, Inc. (NYSE:NEUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Ladies and gentlemen, welcome to the NeueHealth Third Quarter 2024 Earnings Call. My name is Kenneth, and I will be coordinating your call today.
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024. “We are pleased to report another quarter of strong financial performance as we continue to build on the positive momentum we have generated so far this year,” said Mike Mikan, President and CEO of NeueHealth. “We have delivered Adjusted EBITDA profitability for three consecutive quarter.
NeueHealth (NEUE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FAQ
- What is the primary business of NeueHealth?
- What is the ticker symbol for NeueHealth?
- Does NeueHealth pay dividends?
- What sector is NeueHealth in?
- What industry is NeueHealth in?
- What country is NeueHealth based in?
- When did NeueHealth go public?
- Is NeueHealth in the S&P 500?
- Is NeueHealth in the NASDAQ 100?
- Is NeueHealth in the Dow Jones?
- When was NeueHealth's last earnings report?
- When does NeueHealth report earnings?
- Should I buy NeueHealth stock now?